Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,5813,600 of 20,252 grants

Active NON-SBIR/STTR RPGS
Understanding and Targeting the R-Loop-Mediated DNA Damage Response at Telomeres
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Project Summary Oxidative DNA damage is frequently generated by radiation, chemicals, and endogenous oxygen radicals, contributing to genomic instability during both aging and tumo...

$3.5M
USD
Completed OTHER RESEARCH-RELATED
Mechanisms and In Vivo Efficacy of Synergistic Acid Ceramidase and Bcl-2 Inhibition in Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE University of Virginia United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is an aggressive, heterogeneous myeloid malignancy that results in bone marrow failure. The Bcl-2 antagonist/BH3-mimetic, vene...

$380.6K
USD
Active NON-SBIR/STTR RPGS
Novel synthetic lethality strategy for TP53 mutant colorectal cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Genetic alterations in the tumor suppressor p53 gene (TP53) are found in most colorectal adenocarcinomas (CRC) and contributes to poor prognosis. The p53 p...

$5.03M
USD
Active NON-SBIR/STTR RPGS
Therapeutic targeting of master regulators in non-canonical AR driven advanced lethal prostate cancers
NATIONAL CANCER INSTITUTE State University of New York At Buffalo United States 2023 – 2028

PROJECT SUMMARY (ABSTRACT)Androgen receptor (AR) targeted therapies such as abiraterone, enzalutamide, apalutamide, and darolutamide are effective treatments for patients with adva...

$5.03M
USD
Completed OTHER RESEARCH-RELATED
Aging in place for older adults with cancer: The role of physical function and home environment
NATIONAL CANCER INSTITUTE University of Rochester United States 2023 – 2025

Project Summary and Abstract This award will support Dr. Jensen-Battaglia’s long-term goal of developing the expertise and skills needed to become an independent investigator explo...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Ryanodine Receptors as Therapeutic Targets to Prevent Doxorubicin-Induced Lymphatic Dysfunction
NATIONAL CANCER INSTITUTE University of Arkansas for Med Scis United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Lymphedema is a major complication after radiation and/or surgery for breast and gynecological cancers. Advancements in surgical techniques mitigate the ri...

$3.34M
USD
Active OTHER RESEARCH-RELATED
A Paradigm to Examine Cancer Disparities: Limited English Proficient Chinese Patients with Thyroid Nodules
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

PROJECT SUMMARY Asian Americans and Pacific Islanders are the only racial/ethnic group in the United States (US) for whom cancer is the leading cause of death for both sexes. Thus,...

$1.82M
USD
Active NON-SBIR/STTR RPGS
Integrated Imaging Tools for Intercellular Chemokine Signalling
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2026

Chemokines and their G-protein coupled receptors (GPCRs) are key mediators of intercellular signaling between cancer cells and multiple stromal cell types. Cancer cell proliferatio...

$2.19M
USD
Active NON-SBIR/STTR RPGS
Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2023 – 2026

The development of scalable, cost-effective antibody libraries for detecting proteins (or other molecules) has greatly lagged the development of methods for detecting (e.g. by hybr...

$2.22M
USD
Completed NON-SBIR/STTR RPGS
CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2025

PROJECT SUMMARY CAR T cell therapy for solid tumors is hindered by a lack of tumor-specific antigens that are safe to target and homogenously expressed throughout the tumor, diffic...

$14.14M
USD
Active NON-SBIR/STTR RPGS
Using Momentary Measures to Understand Physical Activity Adoption and Maintenance among Pacific Islanders in the United States
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Pacific Islanders represent one of the fastest growing racial/ethnic groups in the United States. Pacific Islanders suffer from disparities in a variety of...

$6.84M
USD
Completed OTHER RESEARCH-RELATED
Mechanisms of gene expression regulation in pancreatic cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2025

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second deadliest cancer within the next 10-years. Investigations into novel mechanisms of PDAC tr...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Engineering Biomaterials to Modulate the Bone Marrow Microenvironment in Multiple Myeloma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

PROJECT SUMMARY Multiple myeloma (MM) accounts for ~23% of all hematologic malignancies with a 2.1% of cancer-related deaths in the United States in 2022. Despite tremendous effort...

$491.9K
USD
Completed OTHER RESEARCH-RELATED
Mechanisms of gene expression regulation in pancreatic cancer
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2023 – 2024

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second deadliest cancer within the next 10-years. Investigations into novel mechanisms of PDAC tr...

$489.7K
USD
Completed OTHER RESEARCH-RELATED
Engineering Biomaterials to Modulate the Bone Marrow Microenvironment in Multiple Myeloma
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2025

PROJECT SUMMARY Multiple myeloma (MM) accounts for ~23% of all hematologic malignancies with a 2.1% of cancer-related deaths in the United States in 2022. Despite tremendous effort...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries
NATIONAL CANCER INSTITUTE Broad Institute, Inc United States 2023 – 2026

The development of scalable, cost-effective antibody libraries for detecting proteins (or other molecules) has greatly lagged the development of methods for detecting (e.g. by hybr...

$2.11M
USD
Active NON-SBIR/STTR RPGS
Using Momentary Measures to Understand Physical Activity Adoption and Maintenance among Pacific Islanders in the United States
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Pacific Islanders represent one of the fastest growing racial/ethnic groups in the United States. Pacific Islanders suffer from disparities in a variety of...

$6.29M
USD
Completed NON-SBIR/STTR RPGS
CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2025

PROJECT SUMMARY CAR T cell therapy for solid tumors is hindered by a lack of tumor-specific antigens that are safe to target and homogenously expressed throughout the tumor, diffic...

$13.43M
USD
Active NON-SBIR/STTR RPGS
Integrated Imaging Tools for Intercellular Chemokine Signalling
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2026

Chemokines and their G-protein coupled receptors (GPCRs) are key mediators of intercellular signaling between cancer cells and multiple stromal cell types. Cancer cell proliferatio...

$2.08M
USD
Active OTHER RESEARCH-RELATED
A Paradigm to Examine Cancer Disparities: Limited English Proficient Chinese Patients with Thyroid Nodules
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

PROJECT SUMMARY Asian Americans and Pacific Islanders are the only racial/ethnic group in the United States (US) for whom cancer is the leading cause of death for both sexes. Thus,...

$1.82M
USD